Scientists at the Garvan Institute are beginning clinical trials with an experimental drug that's designed to make triple negative breast cancer more responsive to chemotherapy.
New drug holds hope for cancer treatment
File photo dated 15/06/06 of a consultant analyzing a mammogram. Source: PA Wire
There could soon be a new treatment option for women diagnosed with an aggressive and difficult to treat form of breast cancer.
Share
